David Sullivan is a physician and chemical pathologist in the Department of Chemical Pathology at Royal Prince Alfred Hospital and Clinical Associate Professor, Faculty of Medicine at the University of Sydney. David has a long-term interest in lipid metabolism with particular emphasis on gene – environment interactions contributing to cardiovascular disease (CVD). Long-term research interests include detection and management of severe inherited dyslipidaemia, such as that seen in Familial Hypercholesterolaemia. David has experience in several international clinical posts, including World Health Organization (WHO) Fellowship at the MRC Lipoprotein Unit, Royal Postgraduate School of Medicine, Hammersmith Hospital, London and co-ordination of international clinical studies from the WHO reference lipid laboratory in Wageningen, Netherlands. He has served on numerous clinical committees including the management committees of the LIPID and FIELD trials. Recent clinical research has focused on diagnostic biomarkers and lipid-lowering treatments based on genetic insights into CVD.